Chlorhexidine Gluconate (Chlorhexidine Gluconate) Patent Expiration, LOE Window & CMS Spending

Chlorhexidine Gluconate (Chlorhexidine Gluconate) by Bajaj Medical: FDA Orange Book LOE 2027-10-02, 10 AB generics, $14.1M 2024 CMS Part D & Medicaid spend, and $1,959 CA SB 17 specialty launch WAC.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorBajaj Medical
FDA Application & PathwayN020111 (NDA)
Exclusivity / Cliff HorizonImmediate Cliff (2025-2027)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2027-10-02
Orange Book Patents (*PED Extensions)2 patents (0 *PED)
Active AB-Rated Generic Competitors10
2024 CMS Total Public Spend$14.1M
2024 Medicare Part D Spend$0
2024 Medicaid Spend$14.1M
Reported Wholesale Price Change (CA SB 17)Specialty launch notice ($1,959 intro WAC)